Vanguard Group Inc Maxcyte, Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Maxcyte, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,565,665 shares of MXCT stock, worth $12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,565,665

Previous 5,429,681 2.5%

Holding current value

$12 Million

Previous $22.6 Million 32.73%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$2.73 - $5.1 $371,236 - $693,518	135,984 Added 2.5%	5,565,665 $15.2 Million
Q4 2024 Feb 11, 2025	SELL	$3.23 - $4.43 $1.12 Million - $1.53 Million	-345,587 Reduced 5.98%	5,429,681 $22.6 Million
Q3 2024 Nov 13, 2024	BUY	$3.68 - $5.06 $478,937 - $658,538	130,146 Added 2.31%	5,775,268 $22.5 Million
Q2 2024 Aug 13, 2024	BUY	$3.63 - $5.0 $1.08 Million - $1.49 Million	298,010 Added 5.57%	5,645,122 $22.1 Million
Q1 2024 May 10, 2024	BUY	$3.94 - $5.38 $256,115 - $349,721	65,004 Added 1.23%	5,347,112 $22.4 Million
Q4 2023 Feb 14, 2024	BUY	$2.6 - $5.24 $632,478 - $1.27 Million	243,261 Added 4.83%	5,282,108 $24.8 Million
Q3 2023 Nov 14, 2023	BUY	$3.02 - $5.1 $205,109 - $346,376	67,917 Added 1.37%	5,038,847 $15.7 Million
Q2 2023 Aug 14, 2023	BUY	$3.69 - $5.35 $304,266 - $441,144	82,457 Added 1.69%	4,970,930 $22.8 Million
Q1 2023 May 15, 2023	BUY	$4.03 - $5.89 $162,634 - $237,696	40,356 Added 0.83%	4,888,473 $24.2 Million
Q4 2022 Feb 10, 2023	BUY	$4.92 - $7.4 $899,361 - $1.35 Million	182,797 Added 3.92%	4,848,117 $26.5 Million
Q3 2022 Nov 14, 2022	BUY	$4.52 - $6.51 $5.74 Million - $8.27 Million	1,269,810 Added 37.4%	4,665,320 $30.3 Million
Q2 2022 Aug 12, 2022	BUY	$3.59 - $6.81 $398,181 - $755,324	110,914 Added 3.38%	3,395,510 $16.1 Million
Q1 2022 May 13, 2022	BUY	$5.26 - $10.84 $667,525 - $1.38 Million	126,906 Added 4.02%	3,284,596 $23 Million
Q4 2021 Feb 14, 2022	BUY	$8.87 - $12.94 $3.58 Million - $5.22 Million	403,373 Added 14.65%	3,157,690 $32.2 Million
Q3 2021 Nov 12, 2021	BUY	$12.21 - $17.2 $33.6 Million - $47.4 Million	2,754,317 New	2,754,317 $33.6 Million

Others Institutions Holding MXCT

# of Institutions

118

Shares Held

71.6M

Call Options Held

Put Options Held

View Full List

About MAXCYTE, INC.

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $219M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

More about MXCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Maxcyte, Inc. Transaction History